ARCHIVES

FDA Approves Tamoxifen For “Reduction In Incidence,” Avoids Word “Prevention”

This article is from The Cancer Letter archive.

Vol. 24 No. 42 | November 6, 1998

Download PDF Visit The Full Archive

Related Articles

In Brief: Ozols Promoted At Fox Chase; Greenberger Moves To Pittsburgh; ACR Names New Officers

October 8, 1993

NCI Advisors Approve New Grant Programs Worth $100 Million

March 27, 2009

Appropriators Project 1.2% Increase for NIH, Due to Budget Plan

June 20, 1997

ASCO Letter To NCI Urges Increased Support for Clinical Trials, Training, Translational Research

March 6, 2009

HHS Reinvention May Include Privatizing Of NIH Clinical Center

May 19, 1995

NIH And E.I. Dupont Sign OncoMouse Agreement.

January 28, 2000